Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.55 |
| ▸ | RBP1 | P09455 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 5/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2412185 | 0.98 | ALOX5 (0.53) | ALOX5RBP1LMNAL3MBTL1NPSR1 | |
| Hydrochloric Acid SCHEMBL9472516 | 0.78 | ALOX5 (0.51) | ALOX5RBP1LMNAL3MBTL1NPSR1 | |
| SCHEMBL2456760 | 0.77 | ALOX5 (0.50) | ALOX5RBP1LMNAL3MBTL1NPSR1 | |
| SCHEMBL9242154 | 0.76 | ALOX5 (0.41) | ALOX5RBP1LMNAL3MBTL1TP53 | |
| SCHEMBL79717 | 0.75 | — | — | |
| SCHEMBL2030838 | 0.75 | ALOX5 (0.47) | ALOX5LMNAL3MBTL1NPSR1POLB | |
| SCHEMBL11329381 | 0.75 | — | — | |
| SCHEMBL1535361 | 0.75 | ALOX5 (0.45) | ALOX5LMNAL3MBTL1NPSR1TP53 | |
| SCHEMBL11218264 | 0.75 | ALDH1A1 (0.50) | ALOX5L3MBTL1NPSR1MAPTCES2 | |
| Hydrochloric Acid SCHEMBL1281247 | 0.75 | ALOX5 (0.49) | ALOX5RBP1LMNAL3MBTL1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020020370-A1 | METHOD FOR PREPARING TRIMETHYLAMMONIUMETHIONYL DIETHYL ESTER IODIDE | 上饶市康可得生物科技有限公司 | 2020-01-30 | — | — | WO | disclosed |
| US-20110313147-A1 | CHROMATOGRAPHIC MATERIAL FOR THE ABSORPTION OF PROTEINS AT PHYSIOLOGICAL IONIC STRENGTH | PALL CORPORATION (US) | 2011-12-22 | — | — | US | disclosed |
| US-8021889-B2 | Chromatographic material for the absorption of proteins at physiological ionic strength | PALL CORPORATION (US) | 2011-09-20 | — | — | US | disclosed |
| EP-1577350-B1 | Method for production of halogen-containing phthalocyanine compound | NIPPON CATALYTIC CHEM IND (JP) | 2011-09-14 | — | — | EP | disclosed |
| US-7473777-B2 | Method for production of halogen-containing phthalocyanine compound | NIPPON SHOKUBAI CO., LTD. (JP) | 2009-01-06 | — | — | US | disclosed |
| US-20070151910-A1 | Chromatographic material for the absorption of proteins at physiological ionic strength | PALL CORPORATION (US) | 2007-07-05 | — | — | US | disclosed |
| EP-1715948-A2 | CHROMATOGRAPHIC MATERIAL FOR THE ABSORPTION OF PROTEINS AT PHYSIOLOGICAL IONIC STRENGTH | Pall Corporation (US) | 2006-11-02 | — | — | EP | disclosed |
| CN-1680380-A | Method for production of halogen-containing phthalocyanine compound | NIPPON CATALYTIC CHEM IND (JP) | 2005-10-12 | — | — | CN | disclosed |
| EP-1577350-A1 | Method for production of halogen-containing phthalocyanine compound | Nippon Shokubai Co., Ltd. (JP) | 2005-09-21 | — | — | EP | disclosed |
| US-20050203293-A1 | Method for production of halogen-containing phthalocyanine compound | NIPPON SHOKUBAI CO., LTD. (JP) | 2005-09-15 | — | — | US | disclosed |
| WO-2005073711-A2 | CHROMATOGRAPHIC MATERIAL FOR THE ABSORPTION OF PROTEINS AT PHYSIOLOGICAL IONIC STRENGTH | PALL CORPORATION (US) | 2005-08-11 | — | — | WO | disclosed |
| US-5214130-A | Synthesis of novel immunosuppressive cyclosporin analogs with modified amino acids at position-8 | MERCK & CO., INC. (US) | 1993-05-25 | — | — | US | disclosed |
| US-5122511-A | IMMUNOSUPPRESSIVE CYCLOSPORIN ANALOGS WITH MODIFIED AMINO ACIDS AT POSITION-8 | MERCK & CO., INC. (US) | 1992-06-16 | — | — | US | disclosed |
| EP-0444897-A1 | Novel immunosuppressive cyclosporin analogs with modified amino acids at position-8 | MERCK & CO. INC. (US) | 1991-09-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110313147-A1 | CHROMATOGRAPHIC MATERIAL FOR THE ABSORPTION OF PROTEINS AT PHYSIOLOGICAL IONIC STRENGTH | SLC7A1, MAX, STAMBP | ALOX5 4801/4885RBP1 1022/4885LMNA 2625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.